Thermo Fisher to buy Qiagen for $11.5bn
03-03-2020
Catalent to buy $1.2bn gene therapy company
17-04-2019
Thermo Fisher to acquire electron microscopy company for $4.2bn
31-05-2016
testing / Shutterstock.com
Biotech company Thermo Fisher Scientific has announced plans to acquire Brammer Bio, a viral vector manufacturer for gene and cell therapies, for $1.7 billion.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Thermo Fisher Scientific, Brammer Bio, M&A, mergers and acquisitions, gene therapy, genetics, genetic disorders
